NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquarter in Kloten, Switzerland.
Fundamentals
Mkt Cap
$16.84M
Volume
-
52W High
$24.60
52W Low
$1.83
PE Ratio
-0.18
Avg. Volume
12,812.73
EPS (Annual)
-$2.16
P/B
0.46
Rev/Employee
$0.00
Earnings
-
39
Bearish Sentiment
How do you feel about NCEL?
FrostyOrbit
$NCEL Has a small market cap ($18M) and only 2.68M shares in the float, creating potential for large moves on catalysts/volume…
FrostyOrbit
$NCEL Raised $1.4M at $4.033/share a 20% premium to the prior close bullish validation from investors.,…